Search Results - "Wu, Alan HB"

Refine Results
  1. 1

    Role of liquid chromatography-high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology by Wu, Alan Hb, Gerona, Roy, Armenian, Patil, French, Deborah, Petrie, Matthew, Lynch, Kara L

    Published in Clinical toxicology (Philadelphia, Pa.) (01-09-2012)
    “…Background. Gas chromatography (GC) and liquid chromatography (LC) coupled with mass spectrometry (MS) are widely used to confirm drug screening results and…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Drug metabolizing enzyme activities versus genetic variances for drug of clinical pharmacogenomic relevance by Wu, Alan Hb

    Published in Clinical proteomics (28-07-2011)
    “…Enzymes are critically important in the transportation, metabolism, and clearance of most therapeutic drugs used in clinical practice today. Many of these…”
    Get full text
    Journal Article
  4. 4

    Development and preliminary clinical validation of a high sensitivity assay for cardiac troponin using a capillary flow (single molecule) fluorescence detector by Wu, Alan H B, Fukushima, Noelle, Puskas, Robert, Todd, John, Goix, Philippe

    Published in Clinical chemistry (Baltimore, Md.) (01-11-2006)
    “…The European Society of Cardiology and the American College of Cardiology (ESC/ACC) have redefined the criteria for the diagnosis of acute myocardial…”
    Get full text
    Journal Article
  5. 5

    National Academy of Clinical Biochemistry Standards of Laboratory Practice: Recommendations for the Use of Cardiac Markers in Coronary Artery Diseases by Wu, Alan H.B, Apple, Fred S, Gibler, W. Brian, Jesse, Robert L, Warshaw, Myron M, Valdes, Roland, Jr

    Published in Clinical chemistry (Baltimore, Md.) (01-07-1999)
    “…The Sixth Conference on the "Standards of Laboratory Practice Series", sponsored by the National Academy of Clinical Biochemistry (NACB), was held on August…”
    Get full text
    Journal Article
  6. 6

    Use of genetic and nongenetic factors in warfarin dosing algorithms by Wu, Alan H B

    Published in Pharmacogenomics (01-07-2007)
    “…Despite the fact that warfarin has been used as an anticoagulant for many years, the safety profile for this drug has been poor. Inappropriate dosing continues…”
    Get more information
    Journal Article
  7. 7

    A 23‐Gene Classifier urine test for prostate cancer prognosis by Guo, Jinan, Johnson, Heather, Zhang, Xuhui, Feng, Xiaoyan, Zhang, Heqiu, Simoulis, Athanasios, Wu, Alan HB, Xia, Taolin, Li, Fei, Tan, Wanlong, Johnson, Allan, Dizeyi, Nishtman, Abrahamsson, Per‐Anders, Kenner, Lukas, Chen, Lingwu, Zhong, Wanmei, Xiao, Kefeng, Persson, Jenny L., Zou, Chang

    Published in Clinical and translational medicine (01-03-2021)
    “…The patients were divided into two risk groups based on diagnosis by the 23-Gene Classifier and Kaplan-Meier survival analysis showed statistically significant…”
    Get full text
    Journal Article
  8. 8

    Gene expression profiles help identify the tissue of origin for metastatic brain cancers by Wu, Alan H B, Drees, Julia C, Wang, Hangpin, VandenBerg, Scott R, Lal, Anita, Henner, William D, Pillai, Raji

    Published in Diagnostic pathology (26-04-2010)
    “…Metastatic brain cancers are the most common intracranial tumor and occur in about 15% of all cancer patients. In up to 10% of these patients, the primary…”
    Get full text
    Journal Article
  9. 9

    Pharmacogenetic testing affects choice of therapy among women considering tamoxifen treatment by Lorizio, Wendy, Rugo, Hope, Beattie, Mary S, Tchu, Simone, Melese, Teri, Melisko, Michelle, Wu, Alan Hb, Lawrence, H Jeffrey, Nikoloff, Michele, Ziv, Elad

    Published in Genome medicine (04-10-2011)
    “…Pharmacogenetic testing holds major promise in allowing physicians to tailor therapy to patients based on genotype. However, there is little data on the impact…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Biological variation of galectin-3 and soluble ST2 for chronic heart failure: Implication on interpretation of test results by Wu, Alan H.B., PhD, DABCC, Wians, Frank, PhD, DABCC, Jaffe, Allan, MD

    Published in The American heart journal (01-06-2013)
    “…Background Galectin-3 and soluble ST2 (sST2) are novel serum biomarkers of chronic heart failure. Methods and Results The biological variability of galectin-3…”
    Get full text
    Journal Article
  13. 13

    Cardiac Troponin and Outcome in Acute Heart Failure by Peacock, W. Frank, De Marco, Teresa, Fonarow, Gregg C, Diercks, Deborah, Wynne, Janet, Apple, Fred S, Wu, Alan H.B

    Published in The New England journal of medicine (15-05-2008)
    “…In this large, retrospective registry study, patients hospitalized with acute decompensated heart failure who had elevated cardiac troponin levels had higher…”
    Get full text
    Journal Article
  14. 14

    Impact of polysubstance use on high-sensitivity cardiac troponin I over time in homeless and unstably housed women by Riley, Elise D., Vittinghoff, Eric, Wu, Alan H.B., Coffin, Phillip O., Hsue, Priscilla Y., Kazi, Dhruv S., Wade, Amanda, Braun, Carl, Lynch, Kara L.

    Published in Drug and alcohol dependence (01-12-2020)
    “…•Cocaethylene and fentanyl are associated with higher levels of hsTnI in poly-drug using women.•Counseling to avoid using cocaine and alcohol in the same two…”
    Get full text
    Journal Article
  15. 15

    Chronic alcohol use does not protect against COVID-19 infection by Lebin, Jacob A., Mudan, Anita, Wu, Alan H.B.

    Published in The American journal of emergency medicine (01-07-2021)
    “…Since the beginning of the coronavirus pandemic, there has been a concurrent global rise in misinformation about the prevention and treatment of coronavirus…”
    Get full text
    Journal Article
  16. 16

    Interpreting Laboratory Results in Transgender Patients on Hormone Therapy by Roberts, Tiffany K., PhD, Kraft, Colleen S., MD, French, Deborah, PhD, Ji, Wuyang, Wu, Alan H.B., PhD, Tangpricha, Vin, MD, PhD, Fantz, Corinne R., PhD

    Published in The American journal of medicine (01-02-2014)
    “…Abstract Background Clinical guidelines recommend laboratory monitoring of transgender persons on cross-sex hormone therapy, but gender-specific reference…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Comparison of Information-Dependent Acquisition on a Tandem Quadrupole TOF vs a Triple Quadrupole Linear Ion Trap Mass Spectrometer for Broad-Spectrum Drug Screening by Thoren, Katie L, Colby, Jennifer M, Shugarts, Sarah B, Wu, Alan H B, Lynch, Kara L

    Published in Clinical chemistry (Baltimore, Md.) (01-01-2016)
    “…Liquid chromatography high-resolution mass spectrometry (LC-HRMS) with untargeted data collection is especially attractive for general unknown drug screening…”
    Get full text
    Journal Article
  19. 19
  20. 20